Covered recipient · General Payments record
DAVID MOUNT
Allopathic & Osteopathic Physicians Internal Medicine Nephrology
General Payments · PY2018–2023
$64,716.21
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Honoraria | $6,239.00 | 3 |
| Consulting Fee | $3,285.00 | 2 |
| Food and Beverage | $340.77 | 5 |
| Education | $104.20 | 2 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Horizon Pharma plc | $6,683.97 | 10 |
| Amgen Inc. | $3,285.00 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $1,314.00 | 10/06/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1020562245 | CMS |
| Amgen Inc. | $1,971.00 | 11/20/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1020562247 | CMS |
| Horizon Therapeutics plc | $64.65 | 10/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987049047 | CMS |
| Horizon Therapeutics plc | $34.90 | 10/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987049049 | CMS |
| Horizon Therapeutics plc | $84.84 | 10/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987049051 | CMS |
| Horizon Therapeutics plc | $46.70 | 10/06/2023 | Education | Undisputed | 01/23/2026 | 987049053 | CMS |
| Horizon Therapeutics plc | $57.50 | 10/06/2023 | Education | Undisputed | 01/23/2026 | 987049055 | CMS |
| Horizon Therapeutics plc | $2,739.00 | 10/06/2023 | Honoraria | Undisputed | 01/23/2026 | 987049057 | CMS |
| Horizon Therapeutics plc | $1,750.00 | 11/04/2023 | Honoraria | Undisputed | 01/23/2026 | 987049059 | CMS |
| Horizon Therapeutics plc | $32.13 | 11/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987049061 | CMS |
| Horizon Therapeutics plc | $124.25 | 11/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987049063 | CMS |
| Horizon Therapeutics plc | $1,750.00 | 11/04/2023 | Honoraria | Undisputed | 01/23/2026 | 987049065 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.